Lidocaine HCl Injection — Class III drug recall D-0552-2026
Ongoing recall by Eugia US LLC, reported 2026-06-10, distributed nationwide. Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
| Recall number | D-0552-2026 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Eugia US LLC, East Windsor, NJ, United States |
| Recall initiated | 2026-05-18 |
| Classified | 2026-05-29 |
| Reported by FDA | 2026-06-10 |
| Distributed | Nationwide (US) |
| Quantity | 168,300 vials |
| Reason classes | labeling |
| NDC | 55150-0164-02, 67777-0419-02, 70121-1049-05, 76420-0760, 76420-0760-01 |
| Lot numbers | 3LC26029A, 3LC26031A, FEB-2029, MAR-2029 |
Product
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Reason for recall
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0552-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.